Oncology Scientific Advancements in the Treatment of Chronic Lymphocytic Leukemia expert roundtables By Ian W. Flinn, MD, PhD; Jeff Sharman, MD; John C. Byrd, MD
Oncology High-Risk Chronic Lymphocytic Leukemia: TP53 Aberrancy in Focus expert roundtables By Ian W. Flinn, MD, PhD; Jeff Sharman, MD; John C. Byrd, MD
Oncology Unmet Needs in Chronic Lymphocytic Leukemia expert roundtables By Ian W. Flinn, MD, PhD; Jeff Sharman, MD; John C. Byrd, MD
Oncology The Future of Chronic Lymphocytic Leukemia Management expert roundtables By Ian W. Flinn, MD, PhD; Jeff Sharman, MD; John C. Byrd, MD
Hepatology Pharmacologic and Nonpharmacologic Interventions for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis expert roundtables By Arun J. Sanyal, MD; Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD; Raymond T. Chung, MD